Our study discovered that NPC patients with low GNA14 expression had a significant decrease in the proportion of most immune cells, such as B cells, CD4+, and CD8+ T cells, and had lower stromal scores and immunity scores, indicating these patients had higher tumor purity and lower levels of immune infiltration (22). This evidence concerns the gene GNA14 and neoplasm.